ABSTRACT I2-O-Tetradecanoylphorbol-13-acetate (TPA) time-dependently inhibited the platelet-acti vating factor (PAF)-induced rise in cytosolic free calcium concentration ([Ca 2+];) in rabbit neutrophils, whereas staurosporine significantly enhanced it. Inositol 1,4,5-trisphosphate (IP3) induced Ca2+ release in digitonin-permeabilized cells but not in PAF-pretreated permeabilized cells. IP3-induced Ca 2+ release was not affected by protein kinase C activators or inhibitors. In the cells pretreated with PAF and thapsigargin in Ca2+-deficient medium, stimulated Ca 2+ entry was evoked by the subsequent addition of CaC12. TPA in hibited the Ca 2+ entry induced by PAF and thapsigargin in a staurosporine-reversible manner but not thap sigargin-induced [Ca 2+]i elevation. These results suggest that protein kinase C negatively regulates PAF and thapsigargin-induced rise in [Ca 21]i possibly by inhibiting Ca 21 store depletion-induced Ca 2+ entry.
Platelet-activating factor (PAF), a potent phospholipid mediator, has been shown to play a crucial role in the pathogenesis of allergic and inflammatory diseases includ ing the processes illustrated by its effects on neutrophils (1) . It has been demonstrated that the effects of PAF on neutrophils are initiated by interacting with specific PAF receptors coupled to phospholipase C leading to the production of inositol 1,4,5-trisphosphate (IP3) and di acylglycerol (1, 2) . Thus, it is established as well that PAF causes an elevation in cytosolic free Ca2+ concentration ([Ca 21]i) via mobilization of Ca 21 from intracellular stores in an IP3-mediated way. In the signaling pathways of neutrophils, protein kinase C (PKC), activated by the latter product, is a key enzyme that plays a crucial role in the regulation of numerous cellular activities in neutro phils. However, the possible interactions between the Ca 21 signaling pathway and PKC have not been thorough ly investigated.
12-O-Tetradecanoylphorbol-13-acetate (TPA) has been previously shown to reduce the number of high affinity PAF binding sites in human neutrophils, and loss of their receptors was observed to correlate well with TPA-in duced inhibition of [Ca 21]i (3). TPA also inhibited fMet Leu-Phe and leukotriene B4-stimulated calcium mobiliza tion in rabbit neutrophils (4) . Therefore, another possibil ity arises that PKC acts on a common process involved in the increase of [Ca 21]i subsequent to each receptor stimu lation. In addition to the mobilization of Ca 21 from in tracellular stores, it is considered that Ca 2+ entry from the extracellular space shares a major part of PAF-in duced rise in [Ca 21]i (5). However, the mechanism of Ca 2+ entry is still largely unknown. In this study, we inves tigated the role of PKC in regulating the PAF-induced changes in [Ca 21]i in rabbit neutrophils. An abstract describing a part of these results has been published (6). Neutrophils were prepared from rabbit whole blood in heparin/EDTA anticoagulant with Polymorphprep (Nycomed Pharma AS, Oslo, Norway). The neutrophils were washed with Ca2+-free Hank's balanced salt solu tion (HBSS) and then suspended in normal HBSS (5 x 106 -10' cells/ml) .
Isolated intact neutrophils (5 x 106 cells/ml) were load ed with 1 pM fura-2/AM for 30 min at 371C. After that, neutrophils were washed twice and resuspended in HBSS at 5 x 106 cells/ml. [Ca 21]i was measured fluorometrically with a fluorescence spectro-fluorometer (F-2000; Hitachi, Tokyo) at 340 nm and 380 nm excitation wavelengths and 510 nm emission wavelengths (7) . To measure the release of Ca" from intracellular Ca" stores, isolated neutro phils (10' cells/ml) were suspended in KH buffer, com posed of 140 mM KCI, 20 mM NaCI, 30 mM HEPES, 1 mM Mg-ATP, 5 mM creatine phosphate and 10 U/ml creatine phosphokinase, and then 0.5,uM fura-2 was added to the suspension before the monitoring. After monitoring was initiated, the cells were permeabilized by 400 nM digitonin in a cuvette. Fluorescence changes were monitored at 321C with a spectro-fluorometer (850, Hitachi), using 340 nm excitation wavelengths and 510 nm emission wavelengths.
For statistical analysis, the peak height of the [Ca 21]i transient and integration of the area over the basal level for 180 sec except for calcium entry (120 sec) after the ad dition of stimulants, shown as a typical pattern in the figures, were calculated by a computer. Statistical ana lyses were performed with Student's t-test.
PAF biphasically induced [Ca 2+]i elevation in rabbit neutrophils with a transient phase followed by a plateau phase. TPA, a phorbol ester type PKC activator, inhibit ed both phases of PAF-induced [Ca 2+]i elevation time dependently (Fig. la) . Peak height was reduced to 32.2 ± 2.5, 20.0 ± 1.7 and 0% of the control, and integrat ed areas were significantly reduced to 51.2±2.5, 36.2±2.9 and 0% of the control by 1 2 and 10-min pretreatment with TPA, respectively (P<0.05, n=3). Phorbol, 4a-TPA, which lacks the ability to activate PKC failed to change the PAF-elevated [Ca 2+]i (data not shown). Mezerein, a non-phorbol ester type PKC activa tor, also inhibited PAF-induced [Ca 2+]i elevation ( (Fig. 1a) . These results suggest that PKC plays an inhibi tory role in regulating PAF-induced changes in [Ca 21]i in rabbit neutrophils, consistent with the previous findings in human neutrophils (3). This was in line with and can be explained by data demonstrating that TPA reduced the number of high affinity PAF binding sites in human neu trophils (3, 8) . It has also been shown that staurosporine increased the concentrations of IP3 and DG and enhanced the plateau phase of [Ca 2+]i elevation by PAF in platelets (9) . Furthermore, PKC has been demonstrated to inter rupt LTB4 receptor binding to G-protein in porcine neu trophils (10). Therefore, it seems possible that PKC also prevents the process subsequent to the receptor activa tion.
Stimulation of phosphoinositide turnover is one of the documented mechanisms of PAF actions in a number of cells. PAF is thought to elevate [Ca 21]i via mobilization of Ca 2+ by IP3 from intracellular Ca 2+ stores and/or stimulation of plasma lemmal Ca2+-entry via receptor operated mechanisms (2) . To analyze this further, we focused on the effects of PKC activators and inhibitors on PAF-induced [Ca 2+]i elevation using two different view points: an IP3-mediated mobilization of Ca 2+ from intra cellular stores and a receptor-operated or store-depletion mediated Ca 2+ entry.
In Ca2+-deficient medium, PAF caused only a transient increase in [Ca 2+]i that was reduced by TPA (Fig. 2a) . This effect of TPA was not due to a depletion of intracel lular Ca 2+ stores because TPA failed to inhibit the thapsi gargin-induced rise in [Ca 2+]i in Ca2+-deficient medium (Fig. 2b) . In the digitonin-permeabilized cells, IP3 re leased Ca 2+ from the intracellular Ca 2+ stores (Fig. 2c) . However, in cells pretreated with PAF and then permeab ilized, IP3 could not produce Ca 2+ release from these cells (Fig. 2d) . Thus, it seems likely that the stimulation of cells with PAF in Ca'-deficient medium causes depletion of IP3-sensitive Ca 2+ stores. Pretreatments of cells with TPA or protein kinase C (19-36), a specific pseudosub strate inhibitor, had no effect on IP3-induced Ca 2+ release (Fig. 2, e and f) . Mezerein and staurosporine also had no effect on it (data not shown). Therefore it seems unlikely that the effects of PKC activators and inhibitors on the PAF-induced rise of [Ca2+]i in Ca'-deficient medium is due to a reduction of responsiveness to IP3 produced by PAF.
After the incubation of cells in Ca'-deficient medium, the addition of Ca' into the medium induced [Ca2+]i ele vation (Fig. 3a) . This [Ca 2+]i elevation would reflect Ca 21 entry from the extracellular space into the cells. In cells pretreated with PAF in Ca2+-deficient medium, the addi tion of Ca2+ caused a large increase in [Ca 2+]i over the control level (Fig. 3a) . Pretreatment with thapsigargin also caused Ca 2+ entry (Fig. 3a) . This effect of thapsi gargin is thought to be due to a depletion of the Ca 2+ store as a consequence of the specific inhibition of the Ca 2+ ATPase of intracellular organelles (11) . Since PAF stim ulation depleted the Ca2+ stores within a few minutes, a common mechanism for the interaction between the Ca 2+ store depletion and Ca 2+ entry underlying the action of PAF and thapsigargin is operative, as recently suggested (12) (13) (14) .
TPA and staurosporine pretreatment had no effect on the spontaneous Ca 2+ entry from the extracellular space observed upon Ca 2+ addition (Fig. 3b) . However, TPA treatment after PAF stimulation inhibited the Ca 2+ entry induced by PAF (Fig. 3c, 19 .4±6.6% of the control integral [Ca 21]i, P<0.05, n=3). Staurosporine pretreat ment prevented the inhibition by TPA (Fig. 3c , 67.2±9.0% of the control, P<0.05 vs TPA alone, n=3). TPA pretreatment also inhibited Ca 2+ entry induced by 200 nM thapsigargin (Fig. 3d, 51 .8±2.9% of the control, P<0.05), and staurosporine attenuated the inhibitory effect of TPA (Fig. 3d, 80.3-L6 .1% of the control, P<0.05 vs TPA alone, n=3). Similar results were ob served in human neutrophils (data not shown). During the course of this study, Tornquist has reported that TPA decreased the influx of Ca 2+ induced by thapsigargin in thyroid FRTL-5 cells (15) . These results suggest at least that the Ca 2+ store depletion-induced Ca 2+ entry might be regulated by PKC.
In summary, the present results suggest that PKC regu lates negatively PAF-induced [Ca 21]i elevation in rabbit and human neutrophils. It seems probable that one of the possible sites of inhibition by PKC of PAF-induced eleva tion of [Ca 2+1i is a process of the Ca 2+ store depletion induced Ca 2+ entry.
